Advancing Novel, Durable, & Effective Ocular Drug Delivery Systems Whilst Improving Patient Adherence, Overcoming Regulatory Hurdles & Addressing Critical Unmet Medical Needs
The 5th Ophthalmic Drug Delivery Summit is where the innovators behind the next generation of ocular therapies come together to solve one critical challenge: getting the right therapy to the right place in the eye.
Hear directly from leaders at Kodiak Sciences, Re-Vana Therapeutics, Ripple Therapeutics, Eli Lilly, Genentech, Sanofi, Astellas, Apellis, Beacon Therapeutics, Kriya Therapeutics and more as they share the latest thinking on long-acting therapies, novel delivery routes, gene and cell therapy, translational science and drug-device integration.
With clinical validation and investment accelerating across the field, this industry-focused, modality and indication-agnostic meeting offers a timely opportunity to benchmark emerging technologies, learn from development successes and setbacks, and connect with the experts tackling the biggest barriers to effective ocular delivery.
I enjoyed the variety of topics and presenters and also liked that the attendees represented diverse functions in the industry.
Associate Director Device Quality, Merck
High quality presentations. Efficient running of the conference.
Chief Scientific Officer, NanOptima
The workshops provided a great opportunity for new-to-industry scientists such as myself to interact in discussions with scientific experts and clinicians
Research Scientist, HTL Biotechnology
Explore the Full Event Guide
- 3 days of cutting-edge ophthalmic drug delivery content
- 3 interactive pre-conference workshops tackling toxicology, cross-functional development and investment readiness
- Long-acting, gene & cell therapy, topical, implantable and suprachoroidal delivery
- Insights from leaders at Eli Lilly, Genentech, Sanofi, Astellas, Apellis, Kodiak Sciences & more
- Speed networking, roundtables, panels and poster sessions designed for meaningful industry connection
2027 Speakers
Official 2027 Partners
Attending Companies Include
Explore The Latest Delivery Innovations
See how long acting, suprachoroidal, implantable and topical technologies are changing the possibilities for ocular therapy to identify approaches that could improve durability, efficacy and patient outcomes.
Meet Experts Shaping the Field
Connect with the scientists, clinicians, developers and technology leaders solving the industry's toughest delivery challenges to build relationships that can accelerate your next program.
Move Your Program Forward
Take practical insights from toxicology and translation through to regulatory, manufacturing and clinical development, helping you de-risk development and accelerate your path to the clinic .